Buckingham Research maintains an Accumulate rating on LifePoint Hospitals (Nasdaq: LPNT), raises price target from $32 to $34.

Buckingham analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE